Comments by "Lepi Doptera" (@lepidoptera9337) on "China's WuXi AppTec In Crosshairs of US Draft Biosecurity Bill" video.

  1. WuXi is, at best, a medium size biotech company. It's a supplier of biologics and services. That's nowhere close to the big bucks that the large pharmaceutical companies are making. There is nothing to beat here.
    2
  2. ​ @pettypractice7872  What about "It's a supplier of biologics and services." did you not understand just now? The point I was making is that WuXi is NOT a competition to the large American companies and it is not even a competition to small biotechs, either. If you want to be specific about CDMOs, then WuXi still ranges behind Samsung Biologics and Lonza. Is the p*ing match over now? ;-)
    2
  3. What's up with the broken Chinese keyboard? ;-)
    1
  4. You can go to WuXi biologics this minute and order e.g. an antibody manufacturing service. Absolutely nobody will stop you. Oh, wait, you don't even know what antibodies are and you don't have a buck fifty to your name. ;-)
    1
  5. Top ten pharmaceutical companies in the world by marketcap. Do you see China on the list? I don't. ;-) 1 Eli Lilly LLY $578.3B 🇺🇸 U.S. 2 Novo Nordisk NVO $452.8B 🇩🇰 Denmark 3 Johnson & Johnson JNJ $377.7B 🇺🇸 U.S. 4 Merck MRK $263.9B 🇺🇸 U.S. 5 AbbVie ABBV $261.2B 🇺🇸 U.S. 6 Roche ROG.SW $222.4B 🇨🇭 Switzerland 7 AstraZeneca AZN $212.2B 🇬🇧 UK 8 Novartis NVS $201.1B 🇨🇭 Switzerland 9 Pfizer PFE $181.3B 🇺🇸 U.S. 10 Amgen AMGN $152.0B 🇺🇸 U.S.
    1